Despite our findings showing no strong correlation between OAS1 expression and tumor neoantigen formation, with the exception of KIRP, READ, and SKCM, further research is required to elucidate the efficacy of OAS1 expression and immune checkpoint blockade therapy within specific tumors. Here, OAS1 is linked to neoplasm.